Reto’s career in cancer research spans over 20 years across academia and the pharmaceutical industry, with significant expertise in cell and molecular biology. He joins LiliumX from Artios Pharma. He previously worked at Imperial College London and spent over 10 years at the Francis Crick Institute and Cancer Research UK, where he characterized the role of DNA and protein damage in cancer development. He gained his PhD from the University of Basel, while working at the Roche Center for Medical Genomics, and was subsequently awarded a Research Fellow Award at the International Agency for Research on Cancer (IARC) in Lyon, France.
Ben completed a PhD at Queen Mary University of London and subsequently worked as a research associate at King’s College London. His previous work has focused on the characterisation of protein structure, dynamics and interactions.
Jack competed his MSc in Molecular Medicine at the University of Sheffield. Since then, he worked at Abcam to help establish their Protein Sciences team. This involved developing a high-throughput antigen screening platform, and working on several tech transfer projects between sites.
Natalie recently completed an MRes in Biomedical Research with Distinction at Imperial College London, studying microbiome-derived metabolite impact on cancer.
Javier holds an MS in Biomedical Physics from the Complutense University of Madrid. He supports LiliumX’s technology development, with a particular interest in protein science and laboratory automation